| Emerging roles of Meis1 in cardiac regeneration, stem cells and cancer M Aksoz, RD Turan, E Albayrak, F Kocabas Current Drug Targets 19 (2), 181-190, 2018 | 32 | 2018 |
| c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... Current cancer drug targets 19 (6), 479-494, 2019 | 30 | 2019 |
| Development of Small Molecule MEIS Inhibitors that modulate HSC activity RD Turan, E Albayrak, M Uslu, P Siyah, LY Alyazici, BM Kalkan, GS Aslan, ... Scientific reports 10 (1), 7994, 2020 | 26 | 2020 |
| Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates G Sir Karakus, C Tastan, D Dilek Kancagi, B Yurtsever, G Tumentemur, ... Scientific reports 11 (1), 5804, 2021 | 18* | 2021 |
| Fluorometric RdRp assay with self-priming RNA F Kocabas, RD Turan, GS Aslan Virus genes 50, 498-504, 2015 | 13 | 2015 |
| Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61. 3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice RD Turan, C Tastan, D Dilek Kancagi, B Yurtsever, G Sir Karakus, S Ozer, ... Scientific reports 11 (1), 15799, 2021 | 12 | 2021 |
| Evolving approaches to heart regeneration by therapeutic stimulation of resident cardiomyocyte cell cycle RD Turan, GS Aslan, D Yucel, R Doger, F Kocabas Anatol J Cardiol 16 (11), 881-886, 2016 | 10 | 2016 |
| Preclinical assessment of efficacy and safety analysis of CAR-T cells (ISIKOK-19) targeting CD19-expressing B-cells for the first Turkish academic clinical trial with relapsed … C Taştan, DD Kançağı, RD Turan, B Yurtsever, D Çakırsoy, S Abanuz, ... Turkish Journal of Hematology 37 (4), 234, 2020 | 9 | 2020 |
| Preliminary report of the academic CAR-T (ISIKOK-19) cell clinical trial in Turkey: Characterization of product and outcomes of clinical application E Erdoğan, K Yalçın, C Hemşinlioğlu, A Sezgin, U Seyis, DD Kancağı, ... Turkish Journal of Hematology 39 (3), 206, 2022 | 5 | 2022 |
| BML‐260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability E Albayrak, S Akgol, RD Turan, M Uslu, F Kocabas Journal of Cellular Biochemistry 123 (12), 2009-2029, 2022 | 4 | 2022 |
| microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model ED Arisan, DA Dart, GH Grant, A Dalby, DD Kancagi, RD Turan, ... ACS omega 7 (42), 38003-38014, 2022 | 4 | 2022 |
| Unusual bifurcation-level variation of the left common carotid artery: anatomic presentation of a surgical case. C Kopuz, R Turan, A Tekat Morphologie: bulletin de l'Association des anatomistes 81 (253), 13-14, 1997 | 3 | 1997 |
| In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A C Hemşinlioğlu, ES Aslan, C Taştan, D Çakırsoy, RD Turan, U Seyis, ... Turkish Journal of Hematology 40 (2), 118, 2023 | 2 | 2023 |
| Pluripotin stimulates the growth of hematopoietic stem cells while suppressing the expansion of bone marrow mesenchymal stem cells and fibroblasts RD Turan, F Kocabaş Journal of Immunology and Regenerative Medicine 15, 100056, 2022 | 2 | 2022 |
| Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease SA Eren, C Tastan, KB Karadeniz, RD Turan, D Cakirsoy, DD Kancagi, ... Current Gene Therapy 23 (4), 304-315, 2023 | 1 | 2023 |
| The effectiveness of ACB-IP 1.0 universal pathogen free concentrated cocktail convalescent plasma in COVID-19 infection C Hemsinlioglu, NB Pelit, K Yalcin, OS Gunaydın, NO Sahin, ES Karagacli, ... medRxiv, 2021.03. 05.21251413, 2021 | 1 | 2021 |
| c-Myc inhibition is critical for HSC expansion and Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... bioRxiv, 403584, 2018 | 1 | 2018 |
| Enhancing CAR-T cells: unleashing lasting impact potential with phytohemagglutinin activation in in vivo leukemia model B Sert, G Gulden, T Teymur, Y Ay, RD Turan, OM Unaldi, E Guzenge, ... Cancer Gene Therapy 31 (3), 387-396, 2024 | | 2024 |
| Combination inhibiting MEIS proteins F Kocabas, RD Turan US Patent 11,602,546, 2023 | | 2023 |
| Phytohemagglutinin-Activated CAR-T Cells: Prolonged Persistence and Enhanced Anti-Tumor Response in CD19-Specific Acute Lymphoblastic Leukemia B Sert, G Gulden, T Teymur, Y Ay, RD Turan, OM Unaldi, E Guzenge, ... bioRxiv, 2023.07. 15.547808, 2023 | | 2023 |
